Table 3.
The prevalence of patients using medication targeting obstructive lung disease in the five regions of Greenland
| Sermersooq | Qeqqa | Kujataa | Avannaa | Disko | P | |
|---|---|---|---|---|---|---|
| (95% CI) (n/N) | (95% CI) (n/N) | (95% CI) (n/N) | (95% CI) (n/N) | (95% CI) (n/N) | ||
| Total prevalence (%) 20–79 years |
8.0 (7.6–8.4) (1,179/14,735) |
7.6 (6.9–8.2) (505/6,680) |
7.2 (6.5–8.0) (339/4,694) |
5.9 (5.4–6.5) (443/7,459) |
8.5 (7.7–9.3) (389/4,596) |
<0.001 |
| Young (%) 20–39 years |
5.1 (4.6–5.7) (339/6,617) |
4.2 (3.5–5.0) (116/2,738) |
3.7 (2.8–4.6) (65/1,758) |
3.3 (2.7–3.9) (102/3,087) |
4.6 (3.6–5.5) (85/1,857) |
<0.001 |
| Seniors (%) 40–79 years |
10.3 (9.7–11.0) (840/8,118) |
9.9 (8.9–10.8) (389/3,942) |
9.3 (8.3–10.4) (274/2,936) |
7.8 (7.0–8.6) (341/4,372) |
11.1 (9.9–12.3) (304/2,739) |
<0.001 |
95% CI = 95% confidence intervals, n/N = number of patients/population, P = p-values.